Page 520 - Microsoft Word - 00 CIMA F1 Prelims STUDENT 2018.docx
P. 520

F2: Advanced Financial Reporting




               19.3 C

                     The redundancy costs will be recognised as an expense and reduce profits in
                     20X9. This would contribute to a reduction in EPS for y/e 20X9 compared to
                     20X8.


                     A scrip issue (AKA bonus issue) is  a free issue of shares to current
                     shareholders based on their existing shareholdings.  As scrip issues raise no
                     cash, they do not contribute to the ability of an entity to generate further profit.
                     Therefore, at the date of issuing, the scrip issue is irrelevant for EPS purposes.
                     EPS considers the scrip issues as if it has always been in existence.


                     When a scrip issue takes place, IAS 33  considers that the scrip issue had
                     already occurred in the comparative period.  The comparative figure will require
                     adjustment to reflect the impact of the scrip issue.

                     If a scrip issue had arisen during 20X9, both the 20X9 and 20X8 EPS figures
                     would have taken account of the 20X9 scrip issue. Therefore, the scrip issue
                     would not contribute to the EPS movement.

                     Dividends paid would be irrelevant to the calculation of EPS. EPS is calculated
                     as profit attributable to ordinary shareholders/ weighted average of ordinary
                     shares. Dividends paid will Dr RE’s and Cr cash. This has no impact on EPS.


                     If a successful product launch caused an  increase in profits, EPS would be
                     expected to increase, not decrease.


               19.4 A

                     Current ratio = Current asset/current liabilities.


                     Revaluations (Dr NCA Cr Revaluation) do not impact any of the figures included
                     within the current ratio. Extra depreciation (Dr Depreciation expense Cr NCA)
                     as a result of the revaluation also has no impact on the above.

                     Gearing and return on capital employed would be affected  as a revaluation
                     surplus would be included in equity, having a direct impact on these
                     calculations.

                     Operating profit margin  will be affected as the revaluation would lead to
                     additional depreciation of $200k in the statement of profit  or loss ($2 million
                     revaluation over 20 year remaining useful life).












               512
   515   516   517   518   519   520   521   522   523   524